<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00715091</url>
  </required_header>
  <id_info>
    <org_study_id>ENRADAS-01</org_study_id>
    <secondary_id>EUDA-CT: 2007-007637-39</secondary_id>
    <nct_id>NCT00715091</nct_id>
  </id_info>
  <brief_title>Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis</brief_title>
  <acronym>ENRADAS</acronym>
  <official_title>Effects of NSAIDs on RAdiographic Damage in Ankylosing Spondylitis (ENRADAS) - a Prospective Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental
      intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren
      Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand
      (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment
      strategy of the control intervention (on-demand) reflects current clinical practice in AS.
      Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3
      months after termination of the trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ankylosing spondylitis (AS) is a common chronic inflammatory rheumatic disease with a
      prevalence of about 0.5%. First symptoms normally occur in young adulthood. Early in its
      course, AS is dominated by chronic pain, fatigue and morning stiffness, later on by ankylosis
      and loss of function. Nonsteroidal anti-inflammatory drugs (NSAID) and tumor necrosis factor
      (TNF) alpha blocking agents are the only drugs with proven efficacy for signs and symptoms.
      It is not clear, however, whether these drugs are also capable of retarding or stopping
      structural damage, i.e. prevention of bony ankylosis. Earlier investigations indicated that
      NSAIDs have, in addition to their anti-inflammatory, also an anti-osteoproliferative effect.
      In this study we will investigate whether treatment with 150 mg diclofenac, a non-selective
      NSAID, on a daily basis (continuous treatment) over 2 years is capable to slow down the
      development of bony ankylosis as compared to treatment with 75-150mg diclofenac as needed
      according to clinical symptoms (on-demand treatment). In this national multi-centre
      randomized trial patients with symptomatic AS and indication for NSAID therapy will be
      enrolled in about 40 centres. The primary outcome parameter is the proportion of patients
      with radiographic progression in the spine after 2 years in each treatment arm. If continuous
      NSAID treatment results in less radiographic progression as compared to on-demand treatment,
      a true disease modifying effect of NSAID has to be assumed which will most likely change the
      place of NSAID treatment in AS.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>radiographic change (mean) of the spine after 2 years in the per-protocol population. Radiographs will be collected and centrally digitized. Scoring will be done by 2 readers who were blinded to treatment and sequence of the films</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the proportions of patients with any progression (change in the mSASSS ≥ 1) and change in the mSASSS &gt; smallest detectable change (SDC), i.e. change in mSASSS which is greater than the measurement error.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ITT analysis of radiographic change.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in VAS back pain, BASDAI, BASFI, BASMI, CRP.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>event rates of serious and non-serious adverse events will be documented and compared between the two groups.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Ankylosing Spondylitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren Resinate), divided into 75mg Voltaren twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment strategy of the control intervention (on-demand) reflects current clinical practice in AS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclophenac</intervention_name>
    <description>continuous (daily) treatment of diclofenac cholestyramine 150 mg, divided into 75mg twice daily</description>
    <arm_group_label>1</arm_group_label>
    <other_name>voltaren resinat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclophenac</intervention_name>
    <description>treatment on-demand (as needed) with diclofenac-cholestyramine 75 to 150 mg daily</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Voltaren resinate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AS according to mod. New York criteria

          -  Patients must have radiographic damage (at least one syndesmophyte) of the spine but
             no complete ankylosis of the cervical and lumbar spine (these are patients at risk for
             further and more rapid radiographic progression)

          -  Patients must have active disease at inclusion defined as BASDAI question 2 (related
             to back pain) &gt;= 4 (VAS, range 0-10) without NSAID treatment and with a clinical
             indication for NSAID therapy based on signs and symptoms

        Exclusion Criteria:

          -  No radiographic damage (syndesmophyte) of the spine at baseline

          -  Complete ankylosis of the cervical and lumbar spine

          -  Inactive disease

          -  Evidence of current or past peptic ulcer

          -  Current or past coronary heart disease

          -  Stroke or transient ischemic attack

          -  Uncontrolled hypertension

          -  Chronic renal failure (creatinine &gt; 1.5mg/dl)

          -  Impaired liver function

          -  Pregnancy

          -  Abnormal liver function (2x upper limit of normal)

          -  Active hepatitis B or C, chronic or acute heart failure (NYHA III or IV) -

          -  History of HIV infection

          -  History of neoplastic disease (details please refer to exclusion criteria)

          -  History of abuse of &quot;hard&quot; drugs or alcoholism

          -  Concomitant treatment with steroids, TNF-blockers, other DMARDs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Rudwaleit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joachim Sieper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jürgen Braun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rheumazentrum Ruhrgebiet, Herne, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Innere Medizin</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>1072076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Jacki</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Manger</name>
      <address>
        <city>Bamberg</city>
        <state>Bayern</state>
        <zip>96047</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Ochs</name>
      <address>
        <city>Bayreuth</city>
        <state>Bayern</state>
        <zip>95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Kellner</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80639</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxiszentrum St. Bonifazius</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81541</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Göttl</name>
      <address>
        <city>Passau</city>
        <state>Bayern</state>
        <zip>94032</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fachklinik Bad Bentheim</name>
      <address>
        <city>Bad Bentheim</city>
        <state>Niedersachsen</state>
        <zip>48455</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Rockwitz</name>
      <address>
        <city>Goslar</city>
        <state>Niedersachsen</state>
        <zip>38640</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. von Hinüber</name>
      <address>
        <city>Hildesheim</city>
        <state>Niedersachsen</state>
        <zip>31134</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Gauler</name>
      <address>
        <city>Osnabrück</city>
        <state>Niedersachsen</state>
        <zip>49076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Dockhorn</name>
      <address>
        <city>Weener</city>
        <state>Niedersachsen</state>
        <zip>26828</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum DüsseldorfKlink für Endokrinologie, Diabetologie und Rheumatologie</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40001</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumatologische Schwerpunktpraxis</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Ratingen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40882</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Kramer</name>
      <address>
        <city>Remscheid</city>
        <state>Nordrhein-Westfalen</state>
        <zip>42897</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Schoo</name>
      <address>
        <city>Rheine</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumatologische Praxis Dr. Spieler</name>
      <address>
        <city>Zerbst</city>
        <state>Sachsen-Anhalt</state>
        <zip>39261</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brandt</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Mielke</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Zinke</name>
      <address>
        <city>Berlin</city>
        <zip>13055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Schwenke</name>
      <address>
        <city>Dresden</city>
        <zip>01109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Pick</name>
      <address>
        <city>Grafschaft bei Bad Neuenahr-Ahrweiler</city>
        <zip>53501</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Kühne</name>
      <address>
        <city>Haldensleben</city>
        <zip>39340</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumazentrum Ruhrgebiet, St. Josefs Krankenhaus</name>
      <address>
        <city>Herne</city>
        <zip>44652</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Josefs-Krankenhaus, Rheumatologie</name>
      <address>
        <city>Herne</city>
        <zip>44652</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Kapelle</name>
      <address>
        <city>Hoyerswerda</city>
        <zip>02977</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Kolitsch</name>
      <address>
        <city>Katzhütte</city>
        <zip>98746</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Gräßler</name>
      <address>
        <city>Pirna</city>
        <zip>01796</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Bohl-Bühler</name>
      <address>
        <city>Potsdam</city>
        <zip>14469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005 Jun;52(6):1756-65.</citation>
    <PMID>15934081</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2008</study_first_submitted>
  <study_first_submitted_qc>July 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2008</study_first_posted>
  <last_update_submitted>August 22, 2014</last_update_submitted>
  <last_update_submitted_qc>August 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>J. Sieper</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>NSAIDS</keyword>
  <keyword>ankylosing spondylitis</keyword>
  <keyword>SpA</keyword>
  <keyword>Spondyloarthritis</keyword>
  <keyword>radiographic changes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Cholestyramine Resin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

